Applied AI Summit Healthcare

Free online conference | April 14-15, 2026

Beyond the Pilot: Scaling and Adopting Unified AI for the 2026

By 2026, the healthcare industry has moved past the hype of Generative AI and into the grueling reality of operational scale. While our industry and all corporations have been flooded with high-performing, use-case-specific AI tools, many health systems have inadvertently created a new “Digital Silo” problem—adding cognitive load to clinicians and medical teams with more complexity rather than reducing it.

This session explores the strategic shift from deploying fragmented “Point Solutions” to building a Unified AI Operating Model. From an overall operations perspective, we will examine the three pillars required to move AI from a successful pilot to an enterprise asset:

  1. Workflow Harmonization: Moving beyond “layering” AI : Discuss how to redesign clinical workflows so AI acts as a teammate that removes administrative burden, rather than a surveillance tool that adds clicks.
  2. The Governance Shield: Treating AI models as a “digital workforce.”: Present a non-technical framework for auditing bias, hallucination, and ROI as part of standard Quality Improvement (QI) cycles.
  3. The Last-Mile Logistics: Solving the gap between data-rich environments and insight-driven care. How to ensure AI outputs reach the front lines at the exact moment of clinical decision-making.
  4. Weigh the Strategic Trade-offs of specialized vs. unified AI architectures.

The session will help attendees will walk away with a solid understanding to evaluate AI maturity, ensure operational and regulatory resilience, and protect the human-centric mission of healthcare in an increasingly algorithmic and complex hybrid world.

Back to speakers

About the speaker

Alice Chung

Field Medical Integrated Engagement & Process Enablement Lead at Genentech

Alice’s current role is focusing on medical affairs at the portfolio level focusing on integrated engagement to bring a holistic approach to support customer engagement effort. In this role, she blends the unique skill sets of domain knowledge in disease states, along with the blend of program management, emerging technology and medical analytics to collaborate with cross-functional stakeholders to design and implement sustainable business strategies across Genentech’s pipeline and inline focused areas. Alice has a diverse and extensive experience in long-term strategy formulation, scenario planning, program design and implementation. She started her Management Consulting career as a trained market researcher conducting market/industry research and program implementation in the Commercial space for Pharmaceutical and Biotechnology clients. Later part of her career she designed and managed complex projects at both US and International level and involved in deeper medical domain knowledge as the strategic partner for medical analytics. Since 2006, Alice has been invited to 49+ conferences associated with Life Sciences Industry trends, KOL summits, Big Data/Advanced analytics, AI/NLP/Text Analytics, Medical Affairs, Digital Health and Innovation conferences (BEI & FEI) as a speaker, facilitator, and panelist to share best practices and innovative programs incorporating use of advanced technology, and analytic methodologies. Alice is also an advisory board member of the Global Innovation Management Institute (GIMI), advocating the practice of innovation and mentoring others who are interested in this discipline. Alice received her education from University of Michigan, University of Chicago, Stanford University on business degrees. Additional education includes graduate programs with MIT on Machine Learning & Artificial Intelligence, Columbia University on Digital Health, University of California- Berkeley on Data Management, and Harvard Medical School on AI for Healthcare (for medical and research).